Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
SRPT
Stock Latest News
The Fly
Sarepta price target lowered to $28 from $30 at JPMorgan
2d ago
SRPT
Premium
Ratings
Sarepta Therapeutics: Overcoming Setbacks with Promising Long-term Potential
2d ago
SRPT
Premium
Class Action
Sarepta Faces Legal Storm Over ELEVIDYS Trial Risks
12d ago
SRPT
Premium
The Fly
FDA flags possible safety signals in new report, says RBC Capital
12d ago
ALKS
ARGX
Premium
Weekend Updates
Sarepta, Circle, Dow, AMD, DoorDash: Trending by Analysts
14d ago
AMD
DOW
Premium
The Fly
Sarepta put volume heavy and directionally bearish
16d ago
SRPT
Premium
The Fly
Solid Biosciences initiated with a Buy at Citi
16d ago
SLDB
SRPT
Premium
The Fly
Sarepta treatment of limb girdle muscular dystrophy granted orphan status
17d ago
SRPT
Premium
The Fly
Oppenheimer biotech analysts hold an analyst/industry conference call
17d ago
SRPT
Premium
Ratings
Sell Rating for Sarepta Therapeutics Amid FDA Investigation and Valuation Concerns
17d ago
SRPT
Premium
The Fly
FDA investigating risk of acute liver failure with Sarepta’s Elevidys
17d ago
SRPT
Premium
The Fly
Sarepta has little value if Elevidys withdrawn, says H.C. Wainwright
17d ago
SRPT
Premium
The Fly
Sarepta price target lowered to $30 from $84 at JPMorgan
20d ago
SRPT
Premium
Weekend Updates
Sutro, Sarepta, Incyte, Signet, Wix: Trending by Analysts
21d ago
SIG
WIX
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
22d ago
ADI
FVR
Premium
The Fly
Circle initiated, Charter upgraded: Wall Street’s top analyst calls
22d ago
EG
CPB
Premium
The Fly
Sarepta price target lowered to $45 from $123 at Oppenheimer
22d ago
SRPT
Premium
The Fly
William Blair downgrades Sarepta on limited near-term upside
22d ago
SRPT
Premium
The Fly
Sarepta downgraded to Market Perform from Outperform at William Blair
22d ago
SRPT
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
24d ago
ACN
SPX
Premium
Market News
Sarepta Stock (SRPT) Could Soar 200% Despite Growing Caution on Wall Street
24d ago
SRPT
Premium
The Fly
SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
24d ago
ON
ADI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.